James Paton

Professor James Paton

Australian Fellow

School of Biological Sciences

Faculty of Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Prof. James Paton is currently a NHMRC Senior Principal Research Fellow (formerly NHMRC Australia Fellow), Professor of Microbiology, and Director, Research Centre for Infectious Diseases (RCID), School of Biological Sciences, University of Adelaide.
As Director of the RCID,he is bringing together established and emerging researchers with synergistic skills to accelerate basic research into bacterial infectious disease pathogenesis, and translate basic discoveries into improved health outcomes.
The major research foci are:
• Basic bacterial pathogenesis and target discovery.
• Vaccine development.
• Novel anti-infectives and therapeutics.
The vision of the RCID is to be the pre-eminent Australian Centre of Excellence in research into the pathogenesis, treatment and prevention of bacterial infectious diseases, and to play a leading role in international collaborative efforts to fight these infections.
Its aims are:
• To build and co-localize a critical mass of researchers with multi-disciplinary expertise, but with a common focus on bacterial infectious diseases.
• To generate new knowledge on bacterial pathogenic mechanisms at a leading international level.
• To make a major contribution to global management of infectious diseases by translating basic research discoveries into new and improved vaccines and novel anti-infectives.
• To significantly increase external research income.
• To foster the professional development of HDR students and ECRs.
• To raise the profile of infectious diseases in the public arena, as well as with State and Federal Governments, with a view to influencing decisions re resource allocation.

    Expand
  • Appointments

    Date Position Institution name
    2013 NHMRC Senior Principal Research Fellow University of Adelaide
    2008 Director, Research Centre for Infectious Diseases University of Adelaide
    2007 - 2013 NHMRC Australia Fellow University of Adelaide
    2000 Professor of Microbiology University of Adelaide
    1980 - 2000 Head, Molecular Microbiology Unit Women's and Children's Hospital
  • Education

    Date Institution name Country Title
    2015 American Academy of Microbiologists United States FAAM
    2013 Academy of Sciences Australia FAA
    1989 Australian Society for Microbiology Australia FASM
    1979 University of Adelaide Australia PhD
    1976 University of Adelaide Australia BSc(Hons)

Investigators

Year

Granting Body

Title of Project

Amount

 

 

 

 

 

R.M. Douglas,J.C. Paton, D. Hansman

 

1981

Merck, Sharp & Dohme Research Laboratories

Antibody response to pneumo-coccal vaccine in Adelaide children.

$8,500

J.C. Paton, D. Hansman

 

 

1982

NHMRC

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

$22,500

J.C. Paton, D. Hansman

 

 

1982

ACH Research Foundation

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

$3,500

I. Toogood, J.C. Paton, D. Hansman

 

1983

ACH Research Foundation

Antibody response to pneumococcal vaccination in children with Thalassemia major.

$6,100

J.C. Paton, D. Hansman

 

 

1983

ACH Research Foundation

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

$3,535

J.C. Paton, D. Hansman

 

 

1983-5

NHMRC

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

$88,266

J.C. Paton, D. Hansman

 

 

1985-6

ACH Research Foundation

Cloning of pneumolysin for development of an improved pneumococcal vaccine.

$48,000

J.C. Paton, D. Hansman

1985-6

ACH Research Foundation

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

 

$36,490

J.C. Paton, A. Lawrence

 

 

 

1986

Channel 10 Children’s Medical Research Foundation

Cloning of Bordetella pertussis virulence determinants as an aid in the diagnosis and prevention of whooping cough.

$10,000

J.C. Paton, D. Hansman

 

 

1987-9

NHMRC

The molecular basis for the pathogenicity of Streptococcus pneumoniae.

$176,407

J.C. Paton

 

 

1987-9

NHMRC

Cloning of Bordetella pertussis virulence determinants.

$98,955

J.C. Paton, D. Hansman

 

1988

ACH Research Foundation

Molecular analysis of pneumococcal virulence.

$8,000

J.C. Paton, P. Goldwater, M. Heuzenroeder

 

1990

ACH Research Foundation

Molecular biological analysis of toxigenic E. coli isolated from cases of SIDS.

$25,000

J.C. Paton, D. Hansman

 

1990-2

NHMRC

Molecular analysis of pneumococcal virulence.

$217,778

J.C. Paton, R. Morona, D. Hansman

 

1990-3

WHO Program for Vaccine Development

Development of an oral pneumococcal vaccine based on recombinant Salmonellae.

$143,750

J.C. Paton, R.J. Harris, P. Goldwater

 

 

1990-1

Channel 7 Children’s Research Foundation

Rapid diagnosis of respiratory infections using the polymerase chain reaction.

$15,000

J.C. Paton, R. Morona, D. Hansman

 

1991-3

NHMRC

Development of an oral pneumococcal vaccine based on recombinant Salmonellae.

$100,373

J.C. Paton, D. Hansman

 

1991

ACH Research Foundation

Molecular analysis of pneumococcal pathogenesis.

$10,000

J.C. Paton, M. Heuzenroeder, P. Goldwater

 

1991

ACH Research Foundation

Molecular biological analysis of toxigenic E. coli isolated from cases of SIDS.

$10,000

J.C. Paton, M. Heuzenroeder, P. Goldwater

 

1991

Sudden Infant Death Research Foundation

Molecular biological analysis of toxigenic E. coli isolated from cases of SIDS.

$30,000

J.C. Paton, R.J. Harris, P. Goldwater

 

1991

ACH Research Foundation

Rapid diagnosis of respiratory infections using the polymerase chain reaction.

$10,000

J.C. Paton

1991

NHMRC

New Brunswick Fermentor (Special Equipment Grant).

 

$26,435

J.C. Paton, G. Boulnois

 

1992-4

RIVM

(Netherlands Inst. for Public Health)

 

Development of pneumolysoid-polysaccharide conjugate vaccine.

$876,568

J.C. Paton

 

 

1992

NHMRC

Production of vaccine antigens (Special Equipment Grant).

$30,000

J.C. Paton, D. Hansman

 

1992

ACH Research Foundation

ACH Research Foundation

$12,420

J.C. Paton, M. Heuzenroeder, P. Goldwater

 

1992

ACH Research Foundation

Molecular biological analysis of toxigenic E. coli isolated from cases of SIDS.

$7,200

J.C. Paton, M. Heuzenroeder, P. Goldwater

 

1992-3

Sudden Infant Death Research Foundation

Molecular biological analysis of toxigenic E. coli isolated from cases of SIDS.

$70,000

J.C. Paton, P. Goldwater

 

 

1993

ACH Research Foundation

Rapid diagnosis of respiratory infections using the polymerase chain reaction.

$20,000

J.C. Paton,  D. Hansman

 

1993-5

NHMRC

Molecular analysis of pneumococcal pathogenesis.

$262,883

J.C. Paton

 

1994

NHMRC

Refrigerated centrifuge (equipment Grant).

$20,000

J.C. Paton

 

 

1994

WCH Research Foundation

Analysis of Shiga-like toxin genes of E. coli.

$35,000

A. Guidolin, J.C. Paton

 

 

1994

WCH Research Foundation

Cloning and analysis of the genes encoding pneumococcal capsule production.

$30,000

J.C. Paton, T. Mitchell, P. Andrew

 

1995

RIVM (Netherlands Inst. for Public Health)

 

Development of a pneumolysoid-polysaccharide conjugate vaccine.

$244,856

J.C. Paton, R. Morona, D. Hansman

 

1995-7

NHMRC

Cloning and analysis of the genes encoding pneumococcal capsule production.

$192,506

J.C. Paton, A.W. Paton

 

 

1995

WCH Research Foundation

Role of Escherichia coli Shiga-like toxins in the pathogenesis of human disease.

$35,000

J.C. Paton, R. Morona

 

 

 

1995

WHO Program for Vaccine Development

Development of an oral pneumococcal vaccine based on Salmonellae expressing pneumolysin derivatives.

$33,731

J.C. Paton, A.W. Paton

 

 

 

1995-7

Channel 7 Children’s Research Foundation

Molecular analysis of virulence factors of group B streptococci.

$80,000

J.C. Paton

1996-8

NHMRC

Molecular analysis of pneumococcal pathogenesis.

 

$315,753

J.C. Paton, P.A. Manning

1996-8

NHMRC

Pathogenesis of Shiga-like toxin-producing Escherichia coli (SLTEC) infection.

 

$221,623

J.C. Paton

1997

NHMRC

Programmable thermal cycler (Special Equipment Grant).

 

$18,000

J.C. Paton

1997

University of Adelaide, Faculty of Medicine

 

Molecular analysis of virulence factors of group B streptococci.

$10,000

J.C. Paton, R. Morona

 

1998-2000

NHMRC

Cloning and analysis of the genes encoding pneumococcal capsule production.

 

$300,734

J.C. Paton

1998-2000

NHMRC

 

Molecular analysis of virulence factors of group B streptococci.

 

$175,354

J.C. Paton, D.E. Briles

 

 

1998-9

WHO Program for Vaccine Development

Development of pneumococcal common protein vaccine.

$120,000

J.C. Paton

1998

Ramaciotti Foundation

Molecular analysis of bacterial pathogenesis: high speed refrigerated centrifuge.

 

$13,000

J.C. Paton, A.D. Ogunniyi

1999

WCH Research

Foundation

Regulation of capsule expression in Streptococcus pneumoniae.

 

$30,000

J.C. Paton

1999

Smith-Kline Beecham

Passive immunization against Streptococcus pneumoniae.

 

$22,000

J.C. Paton

1999-2001

NHMRC

Molecular analysis of pneumococcal pathogenesis.

 

$396,515

J.C. Paton, A.W. Paton

1999-2001

NHMRC

Pathogenesis of Shiga-toxigenic Escherichia coli (STEC) infection.

 

$382,633

J.C. Paton, A.W. Paton, R. Morona

1999-2000

Channel 7 Children’s Research Foundation

Recombinant bacteria expressing a Shiga toxin receptor analogue: a probiotic approach to the prevention of HUS in children.

 

$35,000

J.C. Paton

1999

Smith-Kline Beecham

Novel pneumococcal vaccine antigens.

 

$27,000

J. C. Paton

1999-2000

RIVM (Netherlands Inst. for Public Health)

 

Identification of novel candidate pneumococcal vaccine antigens.

$160,000

J.C. Paton, A.W. Paton, R. Morona

2000

WCH Research

Foundation

Recombinant bacteria expressing a Shiga toxin receptor analogue: a probiotic approach to the prevention of HUS in children.

 

$40,000

A.D. Ogunniyi, J.C. Paton

2000

WCH Research

Foundation

Regulation of capsule expression in Streptococcus pneumoniae.

 

$40,000

J.C. Paton

2000-1

Adelaide University B3

Pathogenesis of group B streptococcal infections.

 

$25,000

J.C. Paton

2001-3

NHMRC

Molecular analysis of  virulence factors of group B streptococci.

 

$211,527

J.C. Paton, R. Morona

2001-3

NHMRC

Genetic analysis of polysaccharide capsule biosynthesis and regulation in Streptococcus pneumoniae.

 

$377,036

A.W. Paton, R. Morona, J.C. Paton

2001

Adelaide University B1

Recombinant bacteria expressing oligosaccharide receptor mimics for treatment and prevention of enteric infections.

 

$12,000

A.W. Paton, R. Morona, J.C. Paton

2001-2

Neose Technologies, Philadelphia, USA.

Recombinant bacteria expressing oligosaccharide receptor mimics for treatment and prevention of enteric infections

 

$388,756

J.C. Paton, A.W. Paton, R. Morona

 

2002

Florey Medical Research Fund

Recombinant bacteria expressing oligosaccharide receptor mimics for treatment of enteric infections.

$100,000

J.C. Paton, A.W. Paton, R. Morona

2002-4

Australian Research Council

Recombinant probiotics for prevention of enteric infections in piglets.

 

$215,972

J.C. Paton

2002-4

NHMRC

Molecular analysis of pneumococcal pathogenesis.

 

$480,000

J.C. Paton, A.W. Paton

2002-4

NHMRC

Pathogenesis of Shiga-toxigenic Escherichia coli (STEC) infection.

 

$510,000

J.C. Paton

2002-4

Meningitis Research Foundation (UK)

Characterization of Streptococcus pneumoniae virulence factors and development of a protein-based vaccine.

 

$272,450

J.C. Paton, A.W. Paton, R. Morona

2003-5

NHMRC Development Grant

Recombinant bacteria expressing oligosaccharide receptor mimics for treatment of enteric infections.

 

$451,056

M.P. Jennings, A.G. McEwan, J.C. Paton

 

2003-5

NHMRC

Oxidative stress and virulence in Streptococcus pneumoniae.

$315,000

J.I Rood, B. Adler, J. Davies, E. Hartland, M. Jennings, A. McEwan, R. Morona, J.C. Paton, A.W. Paton, R. Robins-Browne, R. Strugnell

 

2004-8

NHMRC Program Grant

The molecular basis of bacterial infectious diseases

$16,230,995

 

($4,500,000 for my laboratory)

R. Curtiss III, C. Raetz, H.Y. Kang, S. Hollingshead, J.C. Paton, D.E. Briles, A. Camilli, R. Strugnell, O. Wijburg, M. Cunningham, S. Frey, J. Clemens, A. Tagliabue, S. Kweon

2006-2011

Bill and Melinda Gates Foundation and National Institutes of Health; Grand Challenges in Global Health

A live recombinant attenuated Salmonella anti-pneumococcal vaccine for newborns.

US$ $14,800,000

 

(»AU$660,000 for my laboratory)

A.W. Paton, J.C. Paton, J. Rossjohn

 

 

 

2006-2011

NIH [1R01AI068715-01]

Characterization of a novel AB5 cytotoxin.

US$1,250,000

AU$1.4 mil

J.C. Paton, E.I. Tuomanen, D.E. Briles

2008-2010

PATH Vaccine Solutions

Trivalent pneumococcal protein vaccine: Preclinical optimization, GMP production and Phase I US trial

 

US$588,000

AU$650K

D.E. Briles, J.C. Paton, E.I. Tuomanen

2008-2010

PATH Vaccine Solutions

Pneumococcal vaccine candidates: Efficacy tests in animals

US$759,700

 

AU$840K

 

A.D. Ogunniyi, J.C. Paton, L.K. Mahdi

2008-2011

Meningitis Research Foundation (UK)

Characterization and vaccine potential of pneumococcal virulence factors expressed during meningitis.

 

UK£196,773

 

»AU$437K

J.C. Paton

2007-2012

 

NHMRC

Australia Fellowship

$4,000,000

JK Morona, GW Booker, R Morona, JC Paton

2008

Channel 7 Children’s Medical Research Foundation

Treatment and/or prevention of pneumococcal disease by designing novel drugs targeting capsule biosynthesis proteins CpsB and CpsD

$50,417

 

 

 

 

 

A.W. Paton, J.C. Paton,

2009-2012

NHMRC

Virulence strategies of LEE-negative Shiga toxigenic Escherichia coli.

 

$744,455

A.G. McEwan, M.P. Jennings, J.C. Paton

 

2009-2011

NHMRC

The molecular physiology of Streptococcus pneumoniae during sepsis.

$568,135

CJ Sumby, JA Carver, JC Wallace, M Hrmova, A Pring, AD Abell, GW Booker, MI Bruce, J Brugger, CM Ford, HH Harris, JC Morris, JC Paton, DJ Peet, SM Pyke, KE Shearwin, RI Menz, CA Abbott, PA Anderson, MH Brown, MR Johnston, KA Schuller, AF Lopez, SM Pitson, SF Lincoln, RA McKinnon

 

2009

ARC LIEF

South Australian Facility for Small and Large Molecule X-Ray Diffraction Structure Determination

$560,000

JC Paton, R Morona, AW Paton, AD Ogunniyi, A Jilbert, SR McColl

 

2008

NHMRC Equipment Grant

Facility for in vivo transcriptional analysis of the host-pathogen interaction

$61,000

A. Cooper, D.L. Adelson, B.W. Brook, J.M. Facelli, H.B. Cross, M.I. Stevens, J.C. Paton, T. Kok

2009-2011

ARC Linkage

Environmental genomics: mining, climate change, water, crime and health.

$500,000

J.C. Paton, M.P. Jennings, B. Kobe, A.G. McEwan, R. Morona, A.W. Paton, M.J. Walker

 

2010-2014

NHMRC Program Grant

Pathogenesis, treatment and prevention of bacterial infectious diseases.

$9,427,155

($4.1 million for Adelaide)

J.C. Paton, A.D. Ogunniyi

 

2010-2014

NHMRC Project Grant

Molecular analysis of pneumococcal pathogenesis.

$1,068,030

R. Morona, J.C. Paton, A.W. Paton, C.A. McDevitt

 

2009

NHMRC Equipment Grant

Bacterial cell lysis system

$27,000

A. Lopez, S. Kumar, T. Hughes, H. Scott, G. Goodall, W. Tilley, S. McColl, J.C. Paton, D. Adelson, J. Gecz, J. Melo, B. To.

 

2010

Australian Cancer Research Foundation

South Australian Cancer Genome Facility

$3,500,000

A.W. Paton, R. Morona, J.C. Paton

 

2010-2011

Bill and Melinda Gates Foundation Grand Challenge Explorations

 

A toxin-binding probiotic for prevention of ETEC diarrhea.

US$100,000

(AU$110K)

C.A. McDevitt, J.C. Paton, A.W. Paton, R. Morona, J.C. Wallace, G. Booker

 

2011

NHMRC Equipment Grant

Ultracentrifuge

$78,000

J.C. Paton.

 

2012-2014

ARC Discovery Grant DP120101432

 

Functional characterization of poly-histidine triad proteins.

 

$275,000

C.A. McDevitt, J.C. Paton.

 

2012-2014

ARC Discovery Grant DP120103957

 

The molecular basis for bacterial susceptibility to zinc.

 

$255,000

             

 

 

C.A. McDevitt, J.C. Paton, A.W. Paton, R. Morona, K.E. Shearwin, A. Chapman-Smith, B. Forbes, A.D. Abell.

 

2011

NHMRC Equipment Grant

Temperature controlled protein purification system

$62,042

J.C. Paton, A.D. Ogunniyi, M. Alsharifi, T. Hirst

 

2012-2015

ARC Linkage Grant LP120200244

A single vaccine for influenza and pneumonia.

$276,000

J.C. Paton

2013-2017

NHMRC

Senior Principal Research Fellowship

 

$808,375

J.C. Paton, M.P. Jennings, M. von Itzstein, B. Kobe, M.J. Walker

 

2015-2019

NHMRC Program Grant

Proteins and glycans in host-pathogen interactions: targets for novel drugs and vaccines.

$8,795,785

 

J.C. Paton, C.A. McDevitt

2015-2017

ARC Dicovery Grant DP150104515

 

The critical role of bacterial poly-histidine triad proteins in zinc recruitment.

$384,300

TOTAL

 

 

 

$79,822,851

 

 

 

 

 

    Expand
  • Current Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2018 Co-Supervisor Characterisation of the Function and Vaccine Potential of Surface Exposed Antigens Required for Malaria Parasite Invasion of Human Host Cells Doctor of Philosophy Doctorate Full Time Ms Isabelle Grace Henshall
    2018 Co-Supervisor Molecular basis of Zn(II) transport by the Adc permease Doctor of Philosophy Doctorate Full Time Ms Marina Lauren Zupan
    2018 Co-Supervisor Gamma Irradiated Vaccines Against Respiratory Pathogens Master of Philosophy Master Full Time Miss Zoe Laan
    2018 Co-Supervisor Functional characterisation of a putative Plasmodium falciparum invasion ligand and its homologues Master of Philosophy Master Full Time Mr Juan Miguel Balbin
    2018 Principal Supervisor Quorum Sensing in Streptococcus Pneumoniae Doctor of Philosophy Doctorate Full Time Miss Kimberley Taylor McLean
    2018 Principal Supervisor A molecular characterisation of the bacterium Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Mr Vik Minhas
    2017 Co-Supervisor Functional Analysis of conserved antigens involved in malaria invasion of the host cell. Doctor of Philosophy Doctorate Full Time Mr Benjamin Scott Liffner
    2016 Co-Supervisor Identification and characterisation of invasion inhibitory antimalarial Doctor of Philosophy Doctorate Full Time Miss Amy Lee Burns
    2016 Co-Supervisor The role of CzcD in Zinc homeostasis Doctor of Philosophy Doctorate Full Time Erin Bridget Brazel
  • Past Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2016 - 2018 Co-Supervisor Enhancement of pathogen-specific immunity following co-administration of whole inactivated respiratory vaccines Doctor of Philosophy Doctorate Full Time Dr Shannon Christa David
    2014 - 2016 Co-Supervisor The Molecular Mechanisms of Metal Ion Homeostasis in Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Dr Stephanie Louise Begg
    2013 - 2017 Co-Supervisor Characterisation of the Zinc Homeostatic Mechanisms of Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Miss Jacqueline Rose Morey
    2012 - 2017 Principal Supervisor Biofilm Formation and Virulence of Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Mrs Zarina Amin
    2012 - 2017 Co-Supervisor Development of a Novel Co-vaccination Approach for Pneumococcal and Influenza Infections Doctor of Philosophy Doctorate Full Time Miss Rachelle Babb
    2012 - 2016 Co-Supervisor Haemophilus influenzae survival and biofilm formation in a complex physical, chemical and multispecies environment. Doctor of Philosophy Doctorate Full Time Alexandra Tikhomirova
    2011 - 2015 Co-Supervisor Characterisation Of The ATP-Binding Cassette Tranporters of Pseudomonas aeruginosa Doctor of Philosophy Doctorate Full Time Dr Victoria Grace Pederick
    2010 - 2013 Principal Supervisor Molecular Characterisation of the Polyhistidine Triad Proteins of Streptococcus Pneumoniae Doctor of Philosophy Doctorate Full Time Mr Charles Plumptre
    2010 - 2016 Principal Supervisor Characterisation of Streptococcus pneumoniae opacity phase variation Doctor of Philosophy Doctorate Full Time Miss Melissa Hui Chieh Chai
    2008 - 2012 Principal Supervisor The Role of CpsC in the Regulation of Streptococcus pneumoniae Capsular Polysaccharide Biosynthesis Doctor of Philosophy Doctorate Full Time Mr James Byrne
    2007 - 2013 Co-Supervisor Analysis of Shigella flexneri Cell Surface Virulence Factors Doctor of Philosophy Doctorate Full Time Dr Min Teh
    2007 - 2010 Principal Supervisor Genetic Characterisation of Streptococcus pneumoniae Serotype 1 Isolates in Relation to Invasiveness Doctor of Philosophy Doctorate Full Time Mr Richard Harvey
    2006 - 2010 Principal Supervisor Pathogenesis of Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Dr Lauren McAllister
    2006 - 2010 Co-Supervisor Biogenesis of Shigella flexneri IcsA Protein Doctor of Philosophy Doctorate Full Time Mr Marcin Grabowicz
    2005 - 2011 Co-Supervisor Characterisation of Shigella flexneri polysaccharide co-polymerase (PCP) protein Wzz Doctor of Philosophy Doctorate Full Time Ms Magdalene Papadopoulos
    2004 - 2009 Principal Supervisor Characterisation of a Novel Subtilase Cytotoxin from Shiga Toxigenic Escherichia Coli Doctor of Philosophy Doctorate Full Time Mr Damien Chong
    2003 - 2006 Principal Supervisor Studies of the Two-Component Signal Transduction System RR/HK06 in Streptococcus Pneumoniae Doctor of Philosophy Doctorate Full Time Dr Alistair Standish
    2003 - 2007 Principal Supervisor Differential Expression of Streptococcus Pneumoniae Genes during Pathogenesis Doctor of Philosophy Doctorate Full Time Ms Kim Suk Le Messurier
    2003 - 2007 Co-Supervisor Molecular Characterisation of Shigella flexneri IcsA and the Role Of Lipopolysaccharide O-Antigen in Actin-based Motility Doctor of Philosophy Doctorate Full Time Dr Kerrie May
    2002 - 2006 Principal Supervisor CXC Chemokine Responses of Respiratory Epithelial Cells to Streptococcus pneumoniae Doctor of Philosophy Doctorate Full Time Ms Rikki Graham
    2001 - 2004 Principal Supervisor CXC Chemokine Responses of Intestinal Epithelial Cells to Shiga-toxigenic Escherichia coli Doctor of Philosophy Doctorate Full Time Dr Trisha Rogers
    1999 - 2003 Principal Supervisor Analysis of Putative Virulence Factors of a Locus of Enterocyte Effacement-Negative Shiga-Toxigenic Escherichia Coli 0113:h21 strain Doctor of Philosophy Doctorate Full Time Ms Potjanee Srimanote
  • Position: Australian Fellow
  • Phone: 83135929
  • Email: james.paton@adelaide.edu.au
  • Fax: 8313 3262
  • Campus: North Terrace
  • Building: Molecular Life Sciences, floor 4
  • Room: 4 11
  • Org Unit: Molecular and Biomedical Science

Connect With Me
External Profiles